Marquis Who's Who Honors Matthew B. Smith, MD, for Contributions to Psychiatry
UNIONDALE, NY / ACCESSWIRE / February 4, 2025 / Marquis Who's Who has honored Matthew B. Smith, MD, for contributions to psychiatry.
Within the field of psychiatry, there are practicing professionals who leave behind a lasting legacy through the patients they have served and the lives they have improved. Dr. Smith is a psychiatrist whose exceptional career has earned acclaim from publishers and organizations such as Marquis Who's Who.
Over his 43 years of practice, Dr. Smith has developed advanced expertise in assisting patients with addictions and mood and personality disorders. Furthermore, he has conducted and published research that has furthered the knowledge and dialogue within psychiatry. Dr. Smith is recognized as a leading figure in psychiatry for the lives he has touched and the insights he has shared.
Early Education and Pursuits
Growing up, Dr. Smith lived in several different countries, as his father worked for the American Foreign Service. He credits his father as a significant role model in his success.
From 1970 to 1971, Dr. Smith completed coursework in theater at Sarah Lawrence College, a private liberal arts college in Yonkers, New York. Pursuing his interest in the humanities, he obtained a Bachelor of Arts in English and philosophy in 1972 from Haverford College, a private liberal arts college in Haverford, Pennsylvania.
Medical Training and Certifications
Dr. Smith began his medical training in a pre-med program at Columbia University, an Ivy League university in New York City. He was accepted into the New York University Grossman School of Medicine and graduated with a degree in medicine in 1981. He completed an internship and residency at New York University from 1981 to 1988, followed by a fellowship in academic psychiatry in 1989. He maintains a medical license in New York and board certification through the American Board of Psychiatry and Neurology.
Thriving Psychiatric Practice
Dr. Smith has practiced psychiatry for over 43 years. He holds expertise in treating patients with adult attention deficit disorder (ADHD), brain injuries, mood and personality disorders and addiction.
Dr. Smith now works as a private practice psychiatrist. For 35 years, his office in New York City has treated a diverse array of patients. His services include individual, group and couples therapy, psychopharmacology and neuropsychiatry. Over his many years of practice, he has cultivated a particular interest in helping those with addiction and mood and personality disorders, honing his techniques and treatments.
Awards and Recognition
Dr. Smith's long and successful career in psychiatry has garnered him attention and acclaim. Previously featured in publications such as The Wall Street Journal and Millennium Magazine, Smith received the Albert Nelson Marquis Lifetime Achievement Award for his contributions to psychiatry.
Academic and Creative Works
Beyond his clinical endeavors, Dr. Smith has made additional contributions to psychiatry through research. He has published his research and findings in various professional papers and opinion articles. He also has a passion for writing and performing poetry, frequently reading his original poems at venues across New York City.
Past Achievements and Future Endeavors
Of all his career achievements, Dr. Smith takes great pride in his involvement in advancing psychiatric research and the papers he has published. He also finds exceptional meaning in his experiences with his patients and the connections he has forged.
Looking ahead, Dr. Smith plans to focus on his creative pursuits. He hopes to publish more non-psychiatric writings, including his poetry, within five to 10 years. He will also continue partaking in his other hobbies, such as traveling and enjoying the arts through visiting museums and galleries. As a celebrated psychiatrist who has touched many lives through his practice, Dr. Smith will continue positively contributing to his patients.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms worldwide. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
We use silly voices with each other – and it makes it hard to have a sex life
My wife and I have been together for seven years. I honestly can't remember the last time we had sex – it's been at least a few years. For most of our relationship, I've taken on the role of caretaker. She struggles with anxiety, was recently diagnosed with attention deficit hyperactivity disorder (ADHD) and often needs a lot of emotional hand-holding. Over time, it's taken a toll on how I see our relationship. We also fell into a habit of using silly, childish voices with each other. What started out as playful has ended up making me feel more like her mother than her wife. For a long time, I didn't have much of a libido, and to her credit, she didn't push the issue. But now that my sex drive has returned, it feels as if it's all I can think about – except I just can't seem to feel that way about her any more. Every time I'm briefly tempted to initiate something, it gets snuffed out by the same patterns: the childish behaviour, the emotional neediness, the feeling of being needed more as a caretaker than a partner. Is it possible to break out of this dynamic? Or have we crossed a line that can't be uncrossed? When one partner becomes a caregiver to the other, the erotic charge between them is very likely to be reduced. And when the childlike element you described creeps into the relationship, a sexual taboo arises. Your feeling of being mother to a child is most definitely not sexy; it connects your psyche with a deep and forbidden sense of incest that is never going to allow you to desire your partner. If you want to desire her again you will have to encourage the adult side of her to be present and engage with you as a competent individual in your lives together. It's possible she may have developed some of the behaviours you dislike as a coping mechanism. If you do not want to spend your life mothering her you must refuse to support the childish behaviour, which is a form of control and passive-aggression. The first step would be to have a frank, adult, non-blaming conversation about the state of your union. Validate the parts of her that are mature and self-reliant, and gently let her know that you would be doing her a disservice to support her learned helplessness any longer. Pamela Stephenson Connolly is a US-based psychotherapist who specialises in treating sexual disorders. If you would like advice from Pamela on sexual matters, send us a brief description of your concerns to (please don't send attachments). Each week, Pamela chooses one problem to answer, which will be published online. She regrets that she cannot enter into personal correspondence. Submissions are subject to our terms and conditions.
Yahoo
14 hours ago
- Yahoo
Herbal Medicine Stock With No Sales Rallies 64,000%
(Bloomberg) — A biotech stock focused on herbal medicine has surged by more than 46,000% so far this year and yet, the company itself has made zero revenue — much less turned a profit. As Part of a $45 Billion Push, ICE Prepares for a Vast Expansion of Detention Space As American Architects Gather in Boston, Retrofits Are All the Rage The unbelievable rally has transformed Regencell Bioscience Holdings Limited, a penny stock as recently as April, to one worth nearly $30 billion in market value. A year ago, the stock had a market capitalization of just $53 million. This is despite the company having a net loss of $4.4 million for its fiscal year that ended June 2024, a 28% decrease from the previous year. Earlier this month the company said its board approved a 38-for-1 stock split. When the split took effect Monday, shares rose 283% — their biggest one-day jump in nearly a year on a closing basis — to a record high, triggering more than 10 volatility halts. Shares of the company have been on a bizarre, 460-fold tear in 2025, with little to no news from the firm. The Hong Kong-based firm, which debuted on the Nasdaq Capital Market in 2021, is in the research and development stage and has not generated any revenue since inception, according to its most-recent annual filing with the US Securities and Exchange Commission. A representative for Regencell didn't respond to a Bloomberg News request for comment. Incorporated in the Cayman Islands, the firm aims to treat neurological disorders like ADHD and autism spectrum disorder through traditional herb-based medicines, according to its website. Its traditional Chinese medicine (TCM) formula, which forms the basis of its product candidates, 'contains only natural ingredients without any synthetic components.' 'We have not generated revenue from any TCM formulae candidates or applied for any regulatory approvals, nor have distribution capabilities or experience or any granted patents or pending patent applications and may never be profitable,' the company said in an October filing. The company also made its foray into treatments for Covid-19, conducting trials in 2022 for an 'holistic approach' with its experimental therapy. Regencell said data from a 2022 trial showed the treatment was effective in reducing and eliminating Covid symptoms within six days, although the results were yet to be peer-reviewed. The firm has funded its operations so far, primarily from shareholder loans and proceeds from its initial public offering, the SEC filing showed. It said its gross proceeds from its IPO were $21.85 million, with additional net proceeds of $2.85 million from the issue of the over allotment shares and exercise of 325,000 shares. One potential reason for the outsized swings in Regencell shares: its tiny float. Of its nearly 500 million outstanding shares, only about 30 million are available to be traded. That equates to roughly 6% of shares, compared to Apple Inc. — which has about 98% available — and Tesla Inc.'s 87%. Insiders own the remaining Regencell shares, with Chief Executive Officer Yat-Gai Au's ownership accounting for 86%, according to holding data compiled by Bloomberg. (Updates with closing prices throughout.) American Mid: Hampton Inn's Good-Enough Formula for World Domination The Spying Scandal Rocking the World of HR Software How a Tiny Middleman Could Access Two-Factor Login Codes From Tech Giants US Allies and Adversaries Are Dodging Trump's Tariff Threats As Companies Abandon Climate Pledges, Is There a Silver Lining? ©2025 Bloomberg L.P. Inicia sesión para acceder a tu cartera de valores
Hamilton Spectator
14 hours ago
- Hamilton Spectator
Health-care unions calling for Alberta government to halt plan to limit free vaccines
EDMONTON - Two of Alberta's health-care workers' unions are calling on Alberta Premier Danielle Smith's government to reverse its policy forcing many — including front-line medical staff — to pay for a COVID-19 vaccination. Smith has said the aim of the new policy, announced last week, is to prevent wastage after some $135 million was spent on unused doses. Smith said her government is focused on protecting those who need it the most by giving them the COVID-19 shot for free. That includes those with compromised immune systems, those on social programs and seniors in a congregate setting. However, most Albertans, including health-care workers who don't fall into a high-risk category, and seniors who live independently, will have to pay out of pocket. 'We believe in vaccine choice, but we don't pay for everything,' the premier said last week. United Nurses of Alberta president Heather Smith called it a dangerous and outrageous decision, and warned it will drive even more health-care workers from the province. 'The government's claim that this is being done to save money and recover costs makes no sense from a moral or logical perspective,' Smith said in a statement. She added it will put thousands of Albertans seeking health care at risk when they are most vulnerable, along with endangering thousands of their caregivers. 'It is absolutely irresponsible to force health-care workers in both public and private workplaces to place orders in August and pay to receive a vaccine that is an essential component of workplace health and safety,' said Smith, whose union represents more than 35,000 nurses and allied workers. The province's policy shift comes after the federal government put provinces in charge of buying COVID-19 shots this year. The nurses union was joined by the Health Sciences Association of Alberta, representing 30,000 health-care workers, in calling on the government to continue providing free COVID-19 vaccines this fall. 'That is how we protect patients, reduce hospitalizations, and keep our health system strong,' said union vice-president Leanne Alfaro. Alfaro said COVID-19 continues to put vulnerable Albertans at risk and vaccines remain the most effective tool for protecting individuals and the broader health system, including staff. 'They should not be expected to put themselves in harm's way without basic protection,' she said in a statement. Smith's United Conservative Party government has said it hasn't been determined how much Albertans would pay, but it has estimated the cost to procure each shot is $110. Routine influenza vaccines will continue to be publicly covered. Local pharmacies will no longer be given a supply of COVID-19 shots, which will only be available through public health clinics through a phased delivery in the fall. The government has said the new approach will make sure it's better able to determine what it needs to order in coming years. It has ordered just under 500,000 of the vaccines for the fall, or about one-third of what was ordered last season, at an estimated cost of $49 million. Just under 14 per cent of Alberta's 4.8 million residents were vaccinated for the virus last season. Public health-care experts say the province's new COVID-19 policy will create more barriers to getting vaccinated and also lead to higher costs as more people develop severe complications. Canada's National Advisory Committee on Immunization recommends that all adults 65 years of age or older and health-care workers get the shot. Opposition NDP health critic Sarah Hoffman said Monday that Primary and Preventative Health Minister Adriana Lagrange is responsible for weakening the province's public vaccine campaign in the first place, and her government's goal is to appease anti-vaccination fringe groups. 'This reduced uptake and wastage was a direct result of undermining (LaGrange's) own department's efforts to promote vaccines,' said Hoffman. She said Smith is saddling Albertans with extra fees and inching the province closer to American-style health care. Dr. Luanne Metz said she and other NDP MLAs are hearing from Albertans who are concerned it will force seniors on limited incomes to pay more, which will result in some skipping their medications. 'They're really putting up more and more barriers for people and for health-care workers to be able to get the vaccines, which means that we will have more disease, more sick people, (and) more people dying,' Metz said. This report by The Canadian Press was first published June 16, 2025. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
